Large drugmakers could lose $1 trillion in sales and still be the most profitable industry, analysis shows
Large, brand-name drug manufacturers would still be the most profitable industry sector even with $ 1 trillion fewer sales, all while maintaining current research investments, finds a new analysis of publicly reported financial data by researchers at West Health Policy Center and Johns Hopkins Bloomberg School of Public Health. This builds on previous research by… Read More »